Year

2020

Status

Active

Team

 

Field

Immunology

Location

Oss (NL)

Fund

BGV IV

Citryll

Citryll is developing a first-in-class therapeutic antibody targeting NETosis, a disease pathology associated with a number of inflammatory diseases.